摘要
Cisplatin is widely used in the treatment of many tumors,particularly in ovarian cancer.GST π,metallothionein(MT), multidrug resistance associated proteins(MRPs), nucleotide excision repair(NER), mismatch repair(MMR) and oncogenes contribute to drug resistance of cisplatin.
Cisplatin is widely used in the treatment of many tumors,particularly in ovarian cancer.GST π,metallothionein(MT), multidrug resistance associated proteins(MRPs), nucleotide excision repair(NER), mismatch repair(MMR) and oncogenes contribute to drug resistance of cisplatin.
出处
《现代妇产科进展》
CSCD
2002年第6期475-477,共3页
Progress in Obstetrics and Gynecology